Medline Industries Expands Investment in Georgia Manufacturing Plant to Over $100 Million
09/14/2012
The firm plans to expand capacity at its Lithia Springs, Georgia, production facility by 50 percent and add a fifth machine, bringing its total investment to well over $100 million from the initially planned $65 million.
Medline officials said they already hired about 120 new employees and now plan on adding more employees to support the additional production lines.
"We've had tremendous response from our customers to the new adult incontinence products we're making here," said Dan Love, president of Medline's personal care products division. "As the population ages, there is more and more demand for innovative products like our new FitRight brief, which help people manage their incontinence with dignity."
Medline, the largest privately held manufacturer and distributor of health care supplies in the United States and the leading provider of disposable incontinence products to the long-term care and hospital markets, built the new facility to produce the company's newest and most innovative adult incontinence brand of products called FitRight.
As an incentive the state earlier provided the firm with tax incentives for job creation and Georgia Quick state training grants.
Project Announcements
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
AeroVironment Expands Albuquerque, New Mexico, Manufacturing Operations
03/08/2026
First Quality Home Care Products Plans Archbold, Ohio, Production Facility
03/08/2026
PPG Expands Delaware, Ohio, Manufacturing Operations
03/08/2026
J.M. Smucker Company Expands Topeka, Kansas, Operations
03/05/2026
Novartis Gene Therapies Plans Denton, Texas, Operations
03/04/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025